Skip to content
  • November 24, 2025
Regular-investor.com Regular-investor.com
Regular-investor.com Regular-investor.com
  • Stock Insight
  • Economics
    • Business
    • Financial
  • Investment
    • Dividen
    • Gold
    • Market
  • Nasional
    • Politik
    • Hukum
  • Global
  • Technology
  • Other
    • Lifestyle
    • Sport
    • Syariah
  • Home
  • CNMA
Cinema XXI Akan Buyback Saham: Tunggu Restu Investor di RUPST
November 3, 2025
Dividen

Cinema XXI (CNMA) Umumkan Dividen Interim Rp5 per Saham, Pendapatan Tembus Rp4,3 Triliun di Kuartal III-2025

CNMA Catat Kinerja Positif dan Umumkan Dividen Interim PT Nusantara Sejahtera Raya Tbk (CNMA), pengelola…

author-image
Usman Nurhakim
Read More
Cinema XXI Akan Buyback Saham: Tunggu Restu Investor di RUPST
April 24, 2025
Market

Cinema XXI Catatkan Rugi di Kuartal I-2025, Optimistis Bangkit di Kuartal II

Cinema XXI Alami Penurunan Pendapatan di Kuartal I-2025 Emiten pengelola bioskop Cinema XXI, PT Nusantara…

author-image
Dani Afriyadi Yusuf
Read More
Cinema XXI Akan Buyback Saham: Tunggu Restu Investor di RUPST
October 23, 2024
Dividen

Bisokop Cinema XXI (CNMA) Akan Bagi Dividen Interim Rp 416 Miliar

REGULAR-INVESTOR.COM - PT Nusantara Sejahtera Raya Tbk (CNMA) atau Cinema XXI melaporkan laba bersih setelah…

author-image
Regular Investors
Read More

Recent Posts

  • Investasi Hilirisasi Capai Rp431,4 Triliun per September 2025, Fondasi Transformasi Ekonomi Indonesia
  • PT Djarum Hormati Proses Hukum atas Pencekalan Victor Rachmat Hartono Terkait Dugaan Kasus Pajak
  • GoTo Gelar RUPSLB 17 Desember 2025, Patrick Walujo Mundur dari Jabatan CEO
  • XLSMART Telecom (EXCL) Bagikan Dividen Jumbo Rp2,89 Triliun, Rp159 per Saham
  • MedcoEnergi (MEDC) Resmi Tercatat di OTCQX Best Market dengan Simbol MDCOY

Archives

  • November 2025
  • October 2025
  • September 2025
  • August 2025
  • July 2025
  • June 2025
  • May 2025
  • April 2025
  • March 2025
  • February 2025
  • January 2025
  • December 2024
  • November 2024
  • October 2024
  • May 2024
  • About Us
  • Advertise
  • Careers
  • Contact Us
  • Cyber Media Guidelines
  • Disclaimer
  • Editorial
  • Privacy Policy
  • Terms and Conditions